Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories trade Accounts Receivable, Net ($M) ($M)
Postgres DB financial_values + XBRL
Latest, Q2 2026
8,599
Period ended Jun 30, 2026
Change on a year earlier
+7.9%
7,972 in Q2 2025
History
71 quarters
Since Q4 2007
Sources
68
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Trade Accounts Receivable, Net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 8,599 | +7.9% | Form 10-Q (filed 2026-07-28) ↗ |
| Q1 2026 | Mar 31, 2026 | 8,210 | +12.1% | Form 10-Q (filed 2026-04-29) ↗ |
| Q4 2025 | Dec 31, 2025 | 7,929 | +14.5% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 8,138 | +15.4% | Form 10-Q (filed 2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 7,972 | +16.3% | Form 10-Q (filed 2025-07-30) ↗ |
| Q1 2025 | Mar 31, 2025 | 7,327 | +10.9% | Form 10-Q (filed 2025-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 6,925 | +5.5% | Form 10-K (filed 2025-02-21) ↗ |
| Q3 2024 | Sep 30, 2024 | 7,051 | +8.5% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 6,854 | +11.0% | Form 10-Q (filed 2024-07-31) ↗ |
| Q1 2024 | Mar 31, 2024 | 6,605 | +9.7% | Form 10-Q (filed 2024-05-02) ↗ |
| Q4 2023 | Dec 31, 2023 | 6,565 | +5.6% | Form 10-K (filed 2024-02-16) ↗ |
| Q3 2023 | Sep 30, 2023 | 6,499 | +1.4% | Form 10-Q (filed 2023-11-01) ↗ |
| Q2 2023 | Jun 30, 2023 | 6,172 | -14.3% | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2023 | Mar 31, 2023 | 6,020 | -16.1% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 6,218 | -4.1% | Form 10-K (filed 2023-02-17) ↗ |
| Q3 2022 | Sep 30, 2022 | 6,408 | 0.0% | Form 10-Q (filed 2022-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 7,199 | +17.8% | Form 10-Q (filed 2022-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 7,179 | +17.8% | Form 10-Q (filed 2022-05-03) ↗ |
| Q4 2021 | Dec 31, 2021 | 6,487 | +1.1% | Form 10-K (filed 2022-02-18) ↗ |
| Q3 2021 | Sep 30, 2021 | 6,405 | +13.4% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 6,113 | +18.9% | Form 10-Q (filed 2021-08-04) ↗ |
| Q1 2021 | Mar 31, 2021 | 6,096 | +15.2% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 6,414 | +18.2% | Form 10-K (filed 2021-02-19) ↗ |
| Q3 2020 | Sep 30, 2020 | 5,649 | +3.7% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 5,140 | -7.4% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 5,292 | -1.0% | Form 10-Q (filed 2020-04-29) ↗ |
| Q4 2019 | Dec 31, 2019 | 5,425 | +4.7% | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2019 | Sep 30, 2019 | 5,450 | +3.4% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 5,548 | +6.9% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 5,345 | -0.2% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 5,182 | -1.3% | Form 10-K (filed 2019-02-22) ↗ |
| Q3 2018 | Sep 30, 2018 | 5,271 | +9.8% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 5,192 | +12.1% | Form 10-Q (filed 2018-08-01) ↗ |
| Q1 2018 | Mar 31, 2018 | 5,356 | +18.8% | Form 10-Q (filed 2018-05-02) ↗ |
| Q4 2017 | Dec 31, 2017 | 5,249 | +61.6% | Form 10-K (filed 2018-02-16) ↗ |
| Q3 2017 | Sep 30, 2017 | 4,800 | +44.6% | Form 10-Q (filed 2017-11-02) ↗ |
| Q2 2017 | Jun 30, 2017 | 4,633 | +29.9% | Form 10-Q (filed 2017-08-02) ↗ |
| Q1 2017 | Mar 31, 2017 | 4,510 | +31.5% | Form 10-Q (filed 2017-05-03) ↗ |
| Q4 2016 | Dec 31, 2016 | 3,248 | -5.0% | Form 10-K (filed 2017-02-17) ↗ |
| Q3 2016 | Sep 30, 2016 | 3,320 | -4.0% | Form 10-Q (filed 2016-11-03) ↗ |
| Q2 2016 | Jun 30, 2016 | 3,567 | +0.4% | Form 10-Q (filed 2016-08-03) ↗ |
| Q1 2016 | Mar 31, 2016 | 3,430 | -1.5% | Form 10-Q (filed 2016-05-04) ↗ |
| Q4 2015 | Dec 31, 2015 | 3,418 | -4.7% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2015 | Sep 30, 2015 | 3,460 | -4.4% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 3,553 | -12.4% | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2015 | Mar 31, 2015 | 3,481 | -10.4% | Form 10-Q (filed 2015-05-06) ↗ |
| Q4 2014 | Dec 31, 2014 | 3,586 | -10.0% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 30, 2014 | 3,618 | -6.8% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 30, 2014 | 4,056 | +3.0% | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | 3,883 | -0.9% | Form 10-Q (filed 2014-05-07) ↗ |
| Q4 2013 | Dec 31, 2013 | 3,986 | -47.6% | Form 10-K (filed 2014-02-21) ↗ |
| Q3 2013 | Sep 30, 2013 | 3,883 | -44.1% | Form 10-Q (filed 2013-11-07) ↗ |
| Q2 2013 | Jun 30, 2013 | 3,939 | -41.8% | Form 10-Q (filed 2013-08-06) ↗ |
| Q1 2013 | Mar 31, 2013 | 3,918 | -48.9% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 7,613 | -0.9% | Form 10-K (filed 2014-02-21) ↗ |
| Q3 2012 | Sep 30, 2012 | 6,949 | -1.3% | Form 10-Q (filed 2012-11-07) ↗ |
| Q2 2012 | Jun 30, 2012 | 6,768 | -3.8% | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 7,660 | +7.0% | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 7,684 | +7.0% | Form 10-K (filed 2012-02-21) ↗ |
| Q3 2011 | Sep 30, 2011 | 7,044 | +12.7% | Form 10-Q (filed 2011-11-04) ↗ |
| Q2 2011 | Jun 30, 2011 | 7,038 | +11.0% | Form 10-Q (filed 2011-08-04) ↗ |
| Q1 2011 | Mar 31, 2011 | 7,160 | +9.8% | Form 10-Q (filed 2011-05-06) ↗ |
| Q4 2010 | Dec 31, 2010 | 7,184 | +9.8% | Form 10-K (filed 2011-02-18) ↗ |
| Q3 2010 | Sep 30, 2010 | 6,249 | +14.1% | Form 10-Q (filed 2010-11-05) ↗ |
| Q2 2010 | Jun 30, 2010 | 6,338 | +16.2% | Form 10-Q (filed 2010-08-05) ↗ |
| Q1 2010 | Mar 31, 2010 | 6,520 | – | Form 10-Q (filed 2010-05-04) ↗ |
| Q4 2009 | Dec 31, 2009 | 6,542 | +19.7% | Form 10-K (filed 2010-02-19) ↗ |
| Q3 2009 | Sep 30, 2009 | 5,475 | – | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | 5,453 | – | Form 10-Q (filed 2009-08-07) ↗ |
| Q4 2008 | Dec 31, 2008 | 5,466 | +10.5% | Form 10-Q (filed 2009-08-07) ↗ |
| Q4 2007 | Dec 31, 2007 | 4,947 | – | Form 10-K (filed 2010-02-19) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Trade Accounts Receivable, Net ($M) ($M), quarterly Q4 2007–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-bs-ar
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.